Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eylea
Pharma
Bayer CEO Anderson sticking out firm's revitalization scheme
CEO Bill Anderson thinks Bayer has a good thing going and that it will be better served by adopting a wait-and-see approach for now.
Fraiser Kansteiner
Aug 4, 2026 10:40am
Regeneron revenue up 17% thanks to booming Dupixent sales
Jul 30, 2026 11:26am
After 3 CRLs, FDA approves Outlook's AMD drug Lytenava
Jul 27, 2026 11:51am
Roche defends 6B franc Vabysmo peak target despite another miss
Jul 23, 2026 11:32am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
Biosimilar competiton takes big bite out of Bayer's Eylea sales
May 12, 2026 10:51am
